• 1
    Bouillon R, Okamura WH, Norman AW 1995 Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200257.
  • 2
    Studzinski GP, McLane JA, Uskokovic MR 1993 Signaling pathways for vitamin D induced differentiation: Implications for therapy of proliferative and neoplastic diseases. Crit Rev Eukaryot Gene Expr 3:279312.
  • 3
    Walters MR 1992 Newly identified actions of the vitamin D endocrine system. Endocr Rev 13:719764.
  • 4
    Jones G, Strugnell SA, DeLuca HF 1998 Current understanding of the molecular actions of vitamin D. Physiol Rev 78:11931231.
  • 5
    Holick MF, Schnoes HK, DeLuca HF, Suda T, Cousins RJ 1971 Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochemistry 10:27992804.
  • 6
    Lawson DEM, Fraser DR, Kodicek E, Morris HR, Williams DH 1971 Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism. Nature 230:228230.
  • 7
    Norman AW, Myrtle JF, Midgett RJ, Nowicki HG, Williams V, Popjak G 1971 1,25-dihydroxycholecalciferol: Identification of the proposed active form of vitamin D3 in the intestine. Science 173:5154.
  • 8
    Haussler MR, McCain TA 1977 Basic and clinical concepts related to vitamin D metabolism and action. N Engl J Med 297:974983.
  • 9
    Liao J, Ozone K, Sone T, McDonnell DP, Pike JW 1990 Vitamin D receptor interaction with specific DNA requires a nuclear protein and 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 87:97519755.
  • 10
    Takeyama K-I, Kitanaka S, Sato T, Kobori M, Yanagisawa J, Kato S 1997 25-hydroxyvitamin D3 1α-hydroxylase and vitamin D synthesis. Science 277:18271830.
  • 11
    St-Arnaud R, Messerlian S, Moir JM, Omdahl JL, Glorieux FH 1997 The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J Bone Miner Res 12:15521559.
  • 12
    Shinki T, Shimada H, Wakino S, Anazawa H, Hayashi M, Saruta T, DeLuca HF, Suda T 1997 Cloning and expression of rat 25-hydroxyvitamin D3-1alpha-hydroxylase cDNA. Proc Natl Acad Sci USA 94:1292012925.
  • 13
    Fu GK, Lin D, Zhang MYH, Bikle DD, Shackleton CHL, Miller WL, Portale AA 1997 Cloning of human 25-hydroxyvitamin D-1α-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol 11:19611970.
  • 14
    Monkawa T, Yoshida T, Wakino S, Shinki T, Anazawa H, DeLuca HF, Suda T, Hayashi M, Saruta T 1997 Molecular cloning of cDNA and genomic DNA for human 25-hydroxyvitamin D3-1alpha-hydroxylase. Biochem Biophys Res Commun 239:527533.
  • 15
    Fu GK, Portale AA, Miller WL 1997 Complete structure of the human gene for the vitamin D 1α-hydroxylase, P450c1α. DNA Cell Biol 16:14991507.
  • 16
    Murayama A, Takeyama K-I, Kitanaka S, Kodera Y, Hosoya T, Kato S 1998 The promoter of the human 25-hydroxyvitamin D3 1α-hydroxylase gene confers positive and negative responsiveness to PTH, calcitonin, and 1α,25(OH)2D3. Biochem Biophys Res Commun 249:1116.
  • 17
    Brenza HH, Kimmel-Jehan C, Jehan F, Shinki T, Wakino S, Anazawa H, Suda T, DeLuca HF 1998 Parathyroid hormone activation of the 25-hydroxyvitamin D3-1α-hydroxylase gene promoter. Proc Natl Acad Sci USA 95:13871391.
  • 18
    AusebelFM, BrentR, KingstonRE, MooreDD, SeidmanJG, SmithJA, StruhlK (eds.) 1999 Screening of recombinant DNA libraries. In: Current Protocols in Molecular Biology. John Wiley & Sons, Inc., New York, NY, USA, pp.
  • 19
    Seldin MF, Morse HC, Reeves JP, Scribner JP, LeBoeuf RC, Steinberg AD 1988 Genetic analysis of autoimmune gld mice. I. Identification of a restriction fragment length polymorphism linked to the gld mutation within a conserved linkage group. J Exp Med 167:688693.
  • 20
    Watson ML, Seldin MF 1994 Application of mouse crosses towards defining the genetics of disease phenotypes. Methods Mol Genet 5:369387.
  • 21
    Janicic N, Soliman E, Pausova Z, Seldin MF, Riviere M, Szpirer J, Szpirer C, Hendy GN 1995 Mapping of the calcium-sensing receptor gene (CASR) to human chromosome 3q13.3–21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16. Mamm Genome 6:798801.
  • 22
    Green EL 1981 Linkage, recombination and mapping. In: GreenE (ed.) Genetics and Probability in Animal Breeding Experiments, Macmillan, New York, NY, USA, pp. 77113.
  • 23
    Bishop DT 1985 The information content of phase-known matings for ordering genetic loci. Genet Epidemiol 2:349361.
  • 24
    Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC 1993 Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci USA 90:84248428.
  • 25
    Christakos S 1995 Vitamin D-dependent calcium binding proteins: Chemistry, distribution, functional considerations and molecular biology: Update 1995. Endocr Rev Monogr 4:108110.
  • 26
    Kozak M 1999 Initiation of translation in prokaryotes and eukaryotes. Gene 234:187208.
  • 27
    Nebert DW, Adesnik M, Coon MJ, Estabrook RW, Gonzalez FJ, Guengerich FP, Gunsalus IC, Johnson EF, Kemper B, Levin W 1987 The P450 gene superfamily: Recommended nomenclature. DNA 6:111.
  • 28
    Nebert DW, Gonzalez FJ 1987 P450 genes: Structure, evolution, and regulation. Annu Rev Biochem 56:945993.
  • 29
    Brunette MG, Chan M, Ferriere C, Roberts KD 1978 Site of 1,25(OH)2D synthesis in the kidney. Nature 276:287289.
  • 30
    Kawashima H, Torikai S, Kurokawa K 1981 Localization of 25-hydroxyvitamin D 1α-hydroxylase and 24-hydroxylase along the rat nephron. Proc Natl Acad Sci USA 78:11991203.
  • 31
    Amizuka N, Lee HS, Kwan MY, Azarani A, Warshawsky H, Hendy GN, Ozawa H, White JH, Goltzman D 1997 Cell-specific expression of the parathyroid hormone/parathyroid hormone-related receptor gene in kidney from kidney-specific and ubiquitous promoters. Endocrinology 138:469481.
  • 32
    Boyan BD, Schwartz Z, Swain LD 1992 In vitro studies on the regulation of endochondral ossification by vitamin D. Crit Rev Oral Biol Med 3:1530.
  • 33
    Howard GA, Turner RTT, Sherrard DJ, Baylink DJ 1981 Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. J Biol Chem 256:77387740.
  • 34
    Glorieux FH, St-Arnaud R 1997 Vitamin D pseudodeficiency. In: FeldmanD, GlorieuxFH, PikeJW (eds.) Vitamin D, Academic Press, San Diego, CA, USA, pp. 755764.
  • 35
    Malloy PJ, Pike JW, Feldman D 1997 Hereditary 1,25-dihydroxyvitamin D resistant rickets. In: FeldmanD, GlorieuxFH, PikeJW (eds.) Vitamin D, Academic Press, San Diego, CA, USA, pp. 765787.
  • 36
    Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Sato H, Uchiyama Y, Masushige S, Fukamizu A, Matsumoto T, Kato S 1997 Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16:391396.
  • 37
    Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB 1997 Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 94:98319835.
  • 38
    Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, Delling G, Demay MB 1998 Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia. Endocrinology 139:43914396.
  • 39
    Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB 1999 Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: Formal histomorphometric and biomechanical analyses. Endocrinology 140:49824987.
  • 40
    Balsan S, Garabedian M, Larchet M, Gorski AM, Cournot G, Tau C, Bourdeau A, Silve C, Ricour C 1986 Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J Clin Invest 77:16611667.
  • 41
    Boyan BD, Dean DD, Sylvia VL, Schwartz Z 1994 Nongenomic regulation of extracellular matrix events by vitamin D metabolites. J Cell Biochem 56:331339.
  • 42
    Norman AW 1998 Receptors for 1alpha, 25(OH)2D3: Past, present, and future. J Bone Miner Res 13:13601369.
  • 43
    Axen E, Postlind H, Sjoberg H, Wikvall K 1994 Liver mitochondrial cytochrome P450 CYP27 and recombinant-expressed human CYP27 catalyze 1α-hydroxylation of 25-hydroxyvitamin D3. Proc Natl Acad Sci USA 91:1001410018.
  • 44
    Araya Z, Norlin M, Postlind H 1996 A possible role for CYP27 as a major renal mitochondrial 25-hydroxyvitamin D3-1alpha hydroxylase. FEBS Lett 390:1014.